Cargando…

Prognostic role of serum high mobility group box 1 concentration in cardiac surgery

Outcomes of cardiac surgery are influenced by systemic inflammation. High mobility group box 1 (HMGB1), a pivotal inflammatory mediator, plays a potential role as a prognostic biomarker in cardiovascular disease. The aim of this prospective, observational study was to investigate the relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Namo, Lee, Sak, Lee, Jeong-Rim, Kwak, Young-Lan, Jun, Ji-Hae, Shim, Jae-Kwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156763/ https://www.ncbi.nlm.nih.gov/pubmed/32286371 http://dx.doi.org/10.1038/s41598-020-63051-2

Ejemplares similares

Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: Mechanistic insights associated with high-mobility group box 1
por: Song, Young, et al.
Publicado: (2017)

Evaluation of serum high‐mobility group box 1 concentration in dogs with epilepsy: A case‐control study
por: Koo, Yoonhoi, et al.
Publicado: (2020)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

Clinical signs, duodenal histopathological grades, and serum high‐mobility group box 1 concentrations in dogs with inflammatory bowel disease
por: Lee, Jong‐Hwan, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
por: Lu, Huasong, et al.
Publicado: (2019)

Increased Serum Concentrations of High Mobility Group Box 1 (HMGB1) Protein in Children with Autism Spectrum Disorder
por: Makris, Gerasimos, et al.
Publicado: (2021)

High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation
por: Kim, Sook Young, et al.
Publicado: (2018)

Efficacy of Goal-Directed Therapy Using Bioreactance Cardiac Output Monitoring after Valvular Heart Surgery
por: Lee, Sak, et al.
Publicado: (2015)

Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015)

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
por: Chung, Hye Won, et al.
Publicado: (2009)

Down-Regulation of Serum High-Mobility Group Box 1 Protein in Patients with Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease
por: Kim, Su-Young, et al.
Publicado: (2017)

Prognostic value of the high-mobility group box-1 in young patients with chest pain
por: Haghjooy-Javanmard, Shaghayegh, et al.
Publicado: (2014)

Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure
por: Funayama, Akira, et al.
Publicado: (2013)

Echocardiographic detection of left atrial mobile calcium debris of trido valve surgery: a case report
por: Song, Young, et al.
Publicado: (2014)

Evaluation of serum C-reactive protein and high mobility group box 1 concentrations in 22 dogs with acute pancreatitis: a pilot study
por: Kim, Hakhyun, et al.
Publicado: (2019)

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2012)

The effect of perioperative intravenously administered iron isomaltoside 1000 (Monofer®) on transfusion requirements for patients undergoing complex valvular heart surgery: study protocol for a randomized controlled trial
por: Lee, Seung Hyun, et al.
Publicado: (2018)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Eosinophils Modulate CD4(+) T Cell Responses via High Mobility Group Box-1 in the Pathogenesis of Asthma
por: Shim, Eun-Jin, et al.
Publicado: (2015)

Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response
por: Takahashi, Tetsuya, et al.
Publicado: (2019)

Transcriptional Repression of High-Mobility Group Box 2 by p21 in Radiation-Induced Senescence
por: Kim, Hyun-Kyung, et al.
Publicado: (2018)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
por: Zhou, Yu, et al.
Publicado: (2010)

Serum high-mobility group box-1 protein as a specific marker of severe abdominal injury
por: Sakamoto, Y, et al.
Publicado: (2009)

Second-trimester serum high mobility group box-1 and uterine artery Doppler to predict preeclampsia
por: Wairachpanich, Varangkana, et al.
Publicado: (2022)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Reply from authors: Objective nutritional index as a simple and effective tool for the assessment of mortality risk after cardiac surgery
por: Cho, Jin Sun, et al.
Publicado: (2021)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation–Volvulus Syndrome
por: Troia, Roberta, et al.
Publicado: (2018)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Correlation between Serum Levels of High Mobility Group Box-1 Protein and Pancreatitis: A Meta-Analysis
por: Lin, Yan, et al.
Publicado: (2015)

Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome
por: Wang, Li-Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_giri6puptdfe9h9l3rsusbqn0q